Targeting TGF-β Selectively to Achieve Antifibrotic Efficacy without Safety Concerns

Time: 11:00 am
day: Day Two


• Outlining roles of TGFβ1, 2 and 3, as master regulators of fibrosis
• Exploring pleiotropic effects and challenges in development, immune homeostasis, and cell cycle regulation
• Selective and local inhibition of TGFβ activation may show therapeutic potential for fibrosis indications